Ask the Experts
Dr. Vanessa Zann is Senior Drug Development Consultant at Quotient Sciences. Dr. Zann has over two decards of industry experience providing biopharmaceutics support to discovery, development and clinical programs. She joined Quotient Sciences in 2012 and has led the implementation of Modelling and Simulation and has been heavily involved in the Pharmaceutical Sciences in vitro characterisation strategy, as well as designing clinical studies and providing scientific support through clinical study delivery.
Prior to joining Quotient Sciences, Vanessa worked at AstraZeneca as a permeability expert in the Pharmaceutical Development department. Here, she lead the global Caco-2 facility for development and was responsible for liaising with discovery scientists to ensure the selection of NCE with appropriate biopharmaceutical properties. She introduced the IV microtracer technique and provided biopharmaceutical support to both Discovery and Development programs.
Modelling and simulation, modified-release formulations, design space concepts
In this webinar, Dr. Zann uses case studies to describe the specialized formulation technologies that are available in the “toolbox” to achieve an optimal target product profile for modified-release formulations. She reviews the use of innovative, adaptive clinical programs where human PK data is used to optimize modified-release formulation compositions in real-time.